Management of Amoxicillin-Clavulanate-Associated Diarrhea

Mechanism and Incidence

The American Academy of Pediatrics suggests that amoxicillin-clavulanate causes diarrhea through two distinct mechanisms: dose-dependent gastrointestinal toxicity from clavulanate itself, and disruption of normal intestinal flora leading to potential C. difficile overgrowth 1, 2
Adverse events, primarily diarrhea, occurred in 44-52% of patients receiving high-dose amoxicillin-clavulanate compared to 14-36% with placebo, according to the Pediatric Infectious Diseases Society 3, 4

For mild, non-bloody diarrhea, the Infectious Diseases Society of America recommends continuing the antibiotic if clinically necessary, as most cases are self-limited, and consider switching to twice-daily dosing to reduce gastrointestinal side effects while maintaining efficacy 1, 2, 5
For moderate to severe diarrhea or any red flags, the Clinical Infectious Diseases society advises immediate discontinuation of amoxicillin-clavulanate and testing for C. difficile toxin, and do not use empiric antibiotics for the diarrhea itself while awaiting C. difficile results, unless the patient shows signs of sepsis 7

For respiratory infections, the Rhinology society suggests considering cefuroxime, which showed similar efficacy but lower rates of clinical relapse and less diarrhea in comparative studies 5
For sinusitis, the Rhinology society recommends levofloxacin, which showed comparable efficacy with similar adverse event rates 5
The Pediatric Infectious Diseases Society advises avoiding azithromycin as first-line replacement, as it provides inadequate coverage for common respiratory pathogens and carries risk of QT prolongation 3

For patients requiring amoxicillin-clavulanate who are at high risk for diarrhea, the Praxis Medical Insights guideline recommends using twice-daily dosing regimens preferentially over three-times-daily dosing, and limiting treatment duration to the minimum effective period 1, 2, 6

The Pediatric Infectious Diseases Society notes that antibiotic exposure, particularly early in life, may contribute to long-term adverse health effects, including inflammatory bowel disease, obesity, eczema, and asthma, through disruption of intestinal microbial balance 3, 8